Mount Sinai School of Medicine researchers will present several landmark studies, including data on treatment trends in late-stage cancer, a promising multiple myeloma vaccine, and predictive models of soft tissue sarcomas, prostate and bladder cancer, at the 2012 American Society of Clinical Oncology (ASCO) meeting June 1-5, 2012 in Chicago.
Highlights of Mount Sinai research at ASCO:
•Age, Race, Lower Income, and Lack of Insurance Are Associated with Non-Treatment of Patients With Late-Stage Cancer (Abstract #6065, Monday, June 4, 2012, 1:15 PM-5:15 PM CT, S Hall A2)
